AstraZeneca KK - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Summary

AstraZeneca KK (AstraZeneca), a subsidiary of AstraZeneca Plc is a drug company that provides prescription medicines. The company offers products such as akoreto, arimidex, iressa, inderal, casodex, crestor, and other tablets. It offers products for oncology, cardiovascular and metabolic diseases, respiratory and autoimmune diseases. AstraZeneca also offers treatment of EGFR T790M mutation positive for non-small cell lung cancer. The company has presence in Sapporo, Tokyo, Saitama, Osaka, Hiroshima and Fukuoka. It operates through its factory and distribution center located in Maibara and Ibaraki. AstraZeneca is headquartered in Osaka, Japan.

AstraZeneca KK - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

2
List of Tables 3
List of Figures 4
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AstraZeneca KK, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AstraZeneca KK, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
AstraZeneca Enters Into Co-Promotion Agreement With Ono Pharma For Dapagliflozin 10
AstraZeneca Enters Into Agreement With Bristol-Myers To Commercialize Dapagliflozin In Japan 11
AstraZeneca Enters Into Co-Promotion Agreement With Daiichi Sankyo For Denosumab 11
Acquisition 13
AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 13
AstraZeneca KK - Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables


AstraZeneca KK, Pharmaceuticals & Healthcare, Key Facts 1
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AstraZeneca KK, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AstraZeneca KK, Deals By Therapy Area, 2011 to YTD 2017 8
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AstraZeneca Enters Into Co-Promotion Agreement With Ono Pharma For Dapagliflozin 10
AstraZeneca Enters Into Agreement With Bristol-Myers To Commercialize Dapagliflozin In Japan 11
AstraZeneca Enters Into Co-Promotion Agreement With Daiichi Sankyo For Denosumab 11
AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 13
AstraZeneca KK, Key Competitors 15
AstraZeneca KK, Key Employees 16
AstraZeneca KK, Other Locations 17

List Of Figures


AstraZeneca KK, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

AstraZeneca Full Year Operating Financial

AstraZeneca 2023 Full Year Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry This report is part of the Competitive

USD 750 View Report

AstraZeneca 2023 Third Quarter Operating and Financial Review

AstraZeneca 2023 Third Quarter Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry This report is part of the Competitive

USD 750 View Report

Toyo Kanetsu KK - Strategy, SWOT and Corporate Finance Report

Toyo Kanetsu KK - Strategy, SWOT and Corporate Finance ReportToyo Kanetsu KK - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

Solasia Pharma KK - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Solasia Pharma KK (Solasia Pharma) formerly JapanBridge, Inc. is a pharmaceutical company that provides patient access to Western oncology therapies. The company develops and commercializes oncology therapies and cancer supportive

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available